Moreover, there is no correlation between the intensity of inflammation measured by the NLR (Neutrophil to Lymphocyte Ratio) in lung cancer patients and healthy people, or a correlation between the intensity of inflammation and the immunoexpression level of MFN1, FIS1 proteins, and the stage of lung cancer (p > 0.05; MANOVA test). This evidence concerns the gene FIS1 and lung cancer.